Access cutting-edge nasopharyngeal cancer treatment through this clinical trial at a research site in Dublin. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Dublin location
Access nasopharyngeal cancer specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related nasopharyngeal cancer treatment provided free
Check if you qualify for this nasopharyngeal cancer clinical trial in Dublin, CA
No-Cost Study Care
Local to Dublin
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This phase II trial tests the addition of BMS-986016 (relatlimab) to the usual immunotherapy after initial treatment for nasopharyngeal cancer that has come back after a period of improvement (recurrent) or that has spread from where it first started (primary site) to other places in the body (metastatic). Relatlimab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. The usual approach of treatment is initial treatment with chemotherapy such as the co
Sponsor: National Cancer Institute (NCI)
Yes, this clinical trial (NCT06029270) has an active research site in Dublin, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for nasopharyngeal cancer treatment options in Dublin, CA, this clinical trial (NCT06029270) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Dublin research site is actively enrolling participants for this clinical trial. You'll receive care from experienced nasopharyngeal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all nasopharyngeal cancer clinical trials near you to find additional studies recruiting in your area.
See all head and neck cancer clinical trials recruiting in Dublin — not just this study.
Browse Head and Neck Cancer Trials in Dublin →